Spinal Cord Injury (SCI) is a devastating event with sudden onset of motor and sensory dysfunction. Damage to autonomic neurons at and below the level of injury leads to bowel, bladder, and sexual functional loss. Prevalence of this trauma was formerly found primarily in young patients due to high-energy accidents and contact sports. However, cervical canal stenosis is increasingly found in elderly patients with the progress of our aging society, and susceptibility of elderly patients to easily injure their spinal cord from a fall.
SCI is classified into two types: Acute spinal cord injury and chronic spinal cord injury. Acute spinal cord injury is a traumatic event that results in disturbances to normal sensory, motor, or autonomic function and ultimately affects a patient’s physical, psychological, and social well-being. Chronic spinal cord injury refers to a permanent and/or progressive interruption in the conduction of impulses across the neurons and tracts of the spinal cord.
Spinal cord injury symptoms of injury depend on the severity of the injury and its location on the spinal cord. Symptoms may include partial or complete loss of sensory function or motor control of arms, legs and/or body. The most severe spinal cord injury affects the systems that regulate bowel or bladder control, breathing, heart rate, and blood pressure—most people with spinal cord injury experience chronic pain.
SCI is categorized into traumatic and non-traumatic based on etiology. Traumatic Spinal cord injuries are most often the result of vehicle accidents, followed closely by falls. Non-traumatic spinal cord injury causes may include cancer and osteoporosis, spinal tumors, multiple sclerosis, inflammation of the spinal cord, arthritis, spinal stenosis, and blood loss.
There is no specific Spinal Cord Injury treatment for SCI patients, and currently, surgical intervention and subsequent rehabilitation are the only options for SCI treatment. Although methylprednisolone is administered at the acute stage of injury, a consensus of its use has not yet been reached from the aspects of both safety and effectiveness. Recent developments in stem cell research and numerous preclinical studies have demonstrated the effectiveness of neural precursor cell (NPC) transplantation in animal models of SCI.
DelveInsight's ' Chronic Spinal Cord Injury Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Chronic Spinal Cord Injury epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
The DelveInsight Chronic Spinal Cord Injury epidemiology report gives a thorough understanding of the Chronic Spinal Cord Injury by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Chronic Spinal Cord Injury in the US, Europe, and Japan. The report covers the detailed information of the Chronic Spinal Cord Injury epidemiology scenario in seven major countries (US, EU5, and Japan).
Source:- Spinal Cord Injury Market Growth
Comments
Post a Comment